Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • weibominingdata
    Junior Member
    • Aug 2011
    • 3

    #1

    Inconsistent results of cuffcompare, looking for help

    Hi all,

    I have two transcripts files, a.gtf and b.gtf and I use cuffcompare to compare them. More specifically, I treat one as the reference annotation by putting it after the -r option. The command I use looks like this

    cuffcompare -r a.gtf b.gtf

    The second time, I use b.gtf as the reference annotation using the following command

    cuffcompare -r b.gtf a.gtf

    And I compare the two cuffcmp.stats files generated by these two commands and I find inconsistent number of loci, exons, inrons, almost everything in these two files. For example, there are 35930 loci in b.gtf if it is treated as the reference annotation, but the number of loci will be 35932 if b.gtf is not used as a reference annotation. Detail information are listed below. Can anyone tell me what happened here or give me some suggestions where materials about this are available? I google a lot but do not find explanations. Many thanks.

    # Cuffcompare v1.0.3 | Command line was:
    #cuffcompare -r a.gtf b.gtf
    #

    #= Summary for dataset: b.gtf :
    # Query mRNAs : 89421 in 35932 loci (76334 multi-exon transcripts)
    # (13738 multi-transcript loci, ~2.5 transcripts per locus)
    # Reference mRNAs : 24299 in 17251 loci (24299 multi-exon)
    # Corresponding super-loci: 11479
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 84.0 37.7 - -
    Exon level: 65.8 25.3 75.8 29.1
    Intron level: 92.5 43.0 96.4 44.8
    Intron chain level: 25.6 8.2 100.0 42.0
    Transcript level: 0.0 0.0 0.2 0.0
    Locus level: 32.6 15.6 60.6 29.1
    Missed exons: 3380/130250 ( 2.6%)
    Wrong exons: 160300/338929 ( 47.3%)
    Missed introns: 1358/111559 ( 1.2%)
    Wrong introns: 110851/240016 ( 46.2%)
    Missed loci: 531/17251 ( 3.1%)
    Wrong loci: 22853/35932 ( 63.6%)

    ---------------------------------------------------------

    # Cuffcompare v1.0.3 | Command line was:
    #cuffcompare -r b.gtf a.gtf
    #

    #= Summary for dataset: a.gtf :
    # Query mRNAs : 37750 in 30116 loci (24288 multi-exon transcripts)
    # (5474 multi-transcript loci, ~1.3 transcripts per locus)
    # Reference mRNAs : 91369 in 35930 loci (78396 multi-exon)
    # Corresponding super-loci: 12575
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 41.0 65.0 - -
    Exon level: 25.0 59.6 28.9 68.8
    Intron level: 42.9 92.2 44.7 96.1
    Intron chain level: 8.0 26.0 26.7 86.2
    Transcript level: 0.0 0.0 0.1 0.1
    Locus level: 15.9 19.0 22.7 27.1
    Missed exons: 158434/342083 ( 46.3%)
    Wrong exons: 13453/143700 ( 9.4%)
    Missed introns: 111449/240016 ( 46.4%)
    Wrong introns: 1328/111559 ( 1.2%)
    Missed loci: 21690/35930 ( 60.4%)
    Wrong loci: 10553/30116 ( 35.0%)
  • weibominingdata
    Junior Member
    • Aug 2011
    • 3

    #2
    Could someone answer my question? Please

    Comment

    • songyj
      Member
      • Sep 2011
      • 15

      #3
      I also confused about cuffcmp.stats

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...